S0727 Gemcitabine Hydrochloride and Erlotinib Hydrochloride With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery

NCT00617708 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

134

Enrollment

NIH

Sponsor class

Conditions

Stage IV Pancreatic Cancer

Interventions

BIOLOGICAL: cixutumumab
DRUG: erlotinib hydrochloride
DRUG: gemcitabine hydrochloride

Sponsor

National Cancer Institute (NCI)